Trial site
Centro Cardiologico Monzino S.p.A.
- 22running trials
- 21closed trials
The trials here
What the 44 trials at this site are about, from their registry records.
- Conditions
- Heart failure15 trials
- Obesity7 trials
- Coronary artery disease5 trials
- Type 2 diabetes5 trials
- Chronic kidney disease4 trials
- High blood pressure4 trials
- Stroke4 trials
- Atrial fibrillation3 trials
- Dilated cardiomyopathy3 trials
- Familial hypercholesterolaemia3 trials
- Pulmonary arterial hypertension3 trials
- Type 1 diabetes2 trials
- and 4 more
- Phase
- Phase 327 trials
- Phase 210 trials
- Phase 43 trials
- Phase 2/32 trials
- Status
- Completed21 trials
- Recruiting13 trials
- Not yet recruiting5 trials
- Active, not recruiting4 trials
- Suspended1 trial
- Lead sponsor
- AstraZeneca5 trials
- Eli Lilly and Company4 trials
- Merck Sharp & Dohme LLC4 trials
- Bayer3 trials
- Amgen Inc.2 trials
- and 22 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
Recruiting
Recruiting
Recruiting
Pharmacological optimization in prevention in Heart Failure: A Sex-gap?
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure7 recruiting
- Obesity4 recruiting
- Atrial fibrillation2 recruiting
- Dilated cardiomyopathy2 recruiting
- Type 2 diabetes2 recruiting
- Aortic stenosis1 recruiting
- Chronic kidney disease1 recruiting
- Coronary artery disease1 recruiting
- High blood pressure1 recruiting
- Pulmonary arterial hypertension1 recruiting
- Stroke1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Active, not recruiting
Completed
Completed
Completed
A proof of concept and dose-finding study of XXB750 in patients with heart failure
Completed
Completed
Completed
Completed
Completed
Completed
A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026